GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of why does nobody talk about API source — 68 comments in the full submission. View in context.
1.1k
c/compounding·submitted 5 months ago by u/niels_roos

why does nobody talk about API source

Explainerbranch of 7 comments

Something I noticed reading old threads that I have not seen said out loud. The advice on 503B in this community changed substantially around the start of last year, and nobody went back and updated the older posts. So depending on which thread the search engine hands you, you get two contradictory answers with the…

Read the full submission and all 68 comments →

This branch

7 comments, started 4 months ago
u/slow_logbook54 points·4 months ago

Disagree. What you are describing is consistent with telehealth, not with what you concluded.

replysharereportpermalink
u/rina_sobczak37 points·4 months ago

Slight fix: the number was 97.6, not 99.3. Decimal point, but a fairly consequential one.

replysharereportpermalink
u/amara_kuipers25 points·4 months ago

Slight fix: the number was 97.6, not 99.3.

Disagree on that part. 99.2% and 98.9% on the same vial is normal.

replysharereportpermalink
[removed]9 points·4 months ago

[removed by moderator]

replysharereportpermalink
u/ruben_cabrera20 points·4 months ago

What is the actual shortage list status right now?

replysharereportpermalink
u/camila_sandvik0 points·4 months ago

the the UK situation is different from the US, different regulations

replysharereportpermalink
u/rania_diallo1 point·4 months ago·edited

telehealth costs shortage list plus compounding markup, total varies

replysharereportpermalink

← back to the whole thread

About c/compounding

Compounded GLP-1s as a supply route: the 503A/503B distinction, the shortage-list mechanics that made compounding legal and then didn't, state board rules, telehealth prescriber models, and what a compounding pharmacy will and will not tell you about its API source.

53kmembers
95submissions
Oct 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/compounding
c/compounding rules
  1. Regulatory claims need a citation to the actual rule, notice or docket.
  2. No pharmacy referral codes. Naming a pharmacy is fine; recruiting for it is not.
  3. API source questions are on-topic and pharmacies dodging them is newsworthy.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/formulary_fighteru/usp_appendixu/quiet_moderatoru/prior_auth_pain
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →